HMGB1 induces apoptosis and EMT in association with increased autophagy following H/R injury in cardiomyocytes

International Journal of Molecular Medicine

Volumn 37, Issue 3, 2016, Pages 679-689

  Ouyang, Fan ^a,b   Huang, He ^a,b   Zhang, Mingyu ^b   Chen, Mingxian ^b   Huang, Haobo ^b   Huang, Fang ^b,c   Zhou, Shenghua ^b  

^a Xiangtan Central Hospital   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c First Ospital of Changsha ^*  (China)

Author keywords

Apoptosis; Autophagy; Epithelial to mesenchymal transition; High mobility group box 1; Hypoxia reoxygenation injury

Indexed keywords

BECLIN 1; CALVASCULIN; CASPASE 3; DISCOIDIN; DISCOIDIN DOMAIN RECEPTOR 1; FIBROBLAST SPECIFIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; LENTIVIRUS VECTOR; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; MICRORNA 210; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; HEART INFARCTION; HEART MUSCLE CELL; HYPOXIA; IMMUNOCYTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; CARDIAC MUSCLE CELL; CELL LINE; CYTOLOGY; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

APOPTOSIS; AUTOPHAGY; CELL LINE; EPITHELIAL-MESENCHYMAL TRANSITION; FLOW CYTOMETRY; HMGB1 PROTEIN; HUMANS; MYOCYTES, CARDIAC; SIGNAL TRANSDUCTION;

EID: 84959254123     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2016.2474     Document Type: Article

References (59)

1. Aydin S, Kuloglu T, Aydin S, Kalayci M, Yilmaz M, Çakmak T and Eren MN: Elevated adropin: A candidate diagnostic marker for myocardial infarction in conjunction with troponin-I. Peptides 58: 91-97, 2014.
2. Cabello JB, Burls A, Emparanza JI, Bayliss S and Quinn T: Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev 8: CD007160, 2013.
3. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS, Levin TN, et al; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127: e663-e828, 2013.
4. Brown HF: Synopsis and Review of the American College of Cardiology Foundation/American Heart Association 2013 ST-Elevation Myocardial Infarction Guideline. AACN Adv Crit Care 25: 142-150, 2014.
5. Mitra A, Ray A, Datta R, Sengupta S and Sarkar S: Cardioprotective role of p38 MAPK during myocardial infarction via parallel activation of crystallin B and Nrf2. J Cell Physiol 229: 1272-1282, 2014.
6. Sahoo S and Losordo DW: Exosomes and cardiac repair after myocardial infarction. Circ Res 114: 333-344, 2014.
7. Gai Y, Ma Z, Yu X, Qu S and Sui D: Effect of ginsenoside Rh1 on myocardial injury and heart function in isoproterenol-induced cardiotoxicity in rats. Toxicol Mech Methods 22: 584-591, 2012.
8. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 127: e6-e245, 2013.
9. Cao X, Chen A, Yang P, Song X, Liu Y, Li Z, Wang X, Wang L and Li Y: Alpha-lipoic acid protects cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy. Biochem Biophys Res Commun 441: 935-940, 2013.
10. Verma S, Fedak PW, Weisel RD, Butany J, Rao V, Maitland A, Li RK, Dhillon B and Yau TM: Fundamentals of reperfusion injury for the clinical cardiologist. Circulation 105: 2332-2336, 2002.
11. Feng Y, Hu L, Xu Q, Yuan H, Ba L, He Y and Che H: Cytoprotective role of alpha1-antitrypsin in vascular endothelial cell under hypoxia/reoxygenation condition. J Cardiovasc Pharmacol 66: 96-107, 2015.
12. Cao X, Wang X, Ling Y, Song X, Yang P, Liu Y, Liu L, Wang L, Guo J and Chen A: Comparison of the degree of autophagy in neonatal rat cardiomyocytes and H9c2 cells exposed to hypoxia/reoxygenation. Clin Lab 60: 809-814, 2014.
13. Zhang Y, Hu S and Chen Y: Hepatocyte growth factor suppresses hypoxia/reoxygenation-induced XO activation in cardiac microvascular endothelial cells. Heart Vessels, 2014.
14. Hock R, Furusawa T, Ueda T and Bustin M: HMG chromosomal proteins in development and disease. Trends Cell Biol 17: 72-79, 2007.
15. Zhao X, Kuja-Panula J, Rouhiainen A, Chen YC, Panula P and Rauvala H: High mobility group box-1 (HMGB1; amphoterin) is required for zebrafish brain development. J Biol Chem 286: 23200-23213, 2011.
16. Rauvala H and Rouhiainen A: Physiological and pathophysiological outcomes of the interactions of HMGB1 with cell surface receptors. Biochim Biophys Acta 1799: 164-170, 2010.
17. Stros M: HMGB proteins: Interactions with DNA and chromatin. Biochim Biophys Acta 1799: 101-113, 2010.
18. Zhou X, Hu X, Xie J, Xu C, Xu W and Jiang H: Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: Involvement of Wnt signaling activation. J Biomed Biotechnol 2012: 743879, 2012.
19. Nakamura Y, Suzuki S, Shimizu T, Miyata M, Shishido T, Ikeda K, Saitoh S, Kubota I and Takeishi Y: High mobility group box 1 promotes angiogenesis from bone marrow-derived endothelial progenitor cells after myocardial infarction. J Atheroscler Thromb 22: 570-581, 2015.
20. He YY, Wen Y, Zheng XX and Jiang XJ: Intramyocardial delivery of HMGB1 by a novel thermosensitive hydrogel attenuates cardiac remodeling and improves cardiac function after myocardial infarction. J Cardiovasc Pharmacol 61: 283-290, 2013.
21. Andrassy M, Volz HC, Riedle N, Gitsioudis G, Seidel C, Laohachewin D, Zankl AR, Kaya Z, Bierhaus A, Giannitsis E, et al: HMGB1 as a preDictor of infarct transmurality and functional recovery in patients with myocardial infarction. J Intern Med 270: 245-253, 2011.
22. Xu W, Jiang H, Hu X and Fu W: Effects of high-mobility group box 1 on the expression of Beclin-1 and LC3 proteins following hypoxia and reoxygenation injury in rat cardiomyocytes. Int J Clin Exp Med 7: 5353-5357, 2014.
23. Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ III, et al: Endogenous HMGB1 regulates autophagy. J Cell Biol 190: 881-892, 2010.
24. Kang R, Livesey KM, Zeh HJ III, Lotze MT and Tang D: HMGB1 as an autophagy sensor in oxidative stress. Autophagy 7: 904-906, 2011.
25. Ma S, Wang Y, Chen Y and Cao F: The role of the autophagy in myocardial ischemia/reperfusion injury. Biochim Biophys Acta 1852: 271-276, 2015.
26. Sciarretta S, Hariharan N, Monden Y, Zablocki D and Sadoshima J: Is autophagy in response to ischemia and reperfusion protective or detrimental for the heart? Pediatr Cardiol 32: 275-281, 2011.
27. Biswas S, Roy S, Banerjee J, Hussain SR, Khanna S, Meenakshisundaram G, Kuppusamy P, Friedman A and Sen CK: Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds. Proc Natl Acad Sci USA 107: 6976-6981, 2010.
28. Devlin C, Greco S, Martelli F and Ivan M: miR-210: More than a silent player in hypoxia. IUBMB Life 63: 94-100, 2011.
29. Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, et al: hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer 116: 2148-2158, 2010.
30. Feng GM, Chen JH, Lin CI and Yang JM: Effect of docosahexaenoic acid on hypoxia/reoxygenation injury in human coronary arterial smooth muscle cells. Eur J Nutr 51: 987-995, 2012.
31. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
32. Jensen FB, Hansen MN, Montesanti G and Wang T: Nitric oxide metabolites during anoxia and reoxygenation in the anoxia-tolerant vertebrate Trachemys scripta. J Exp Biol 217: 423-431, 2014.
33. Robertson SJ, Mokgokong R, Kania KD, Guedj AS, Hladky SB and Barrand MA: Nitric oxide contributes to hypoxia-reoxygenation-induced P-glycoprotein expression in rat brain endothelial cells. Cell Mol Neurobiol 31: 1103-1111, 2011.
34. Rus A, Molina F, Peinado MA and Del Moral ML: Nitric oxide averts hypoxia-induced damage during reoxygenation in rat heart. Microsc Res Tech 74: 1093-1103, 2011.
35. Kim JS, Wang JH and Lemasters JJ: Mitochondrial permeability transition in rat hepatocytes after anoxia/reoxygenation: Role of Ca2+-dependent mitochondrial formation of reactive oxygen species. Am J Physiol Gastrointest Liver Physiol 302: G723-G731, 2012.
36. Kondoh M, Ohga N, Akiyama K, Hida Y, Maishi N, Towfik AM, Inoue N, Shindoh M and Hida K: Hypoxia-induced reactive oxygen species cause chromosomal abnormalities in endothelial cells in the tumor microenvironment. PLoS One 8: e80349, 2013.
37. Xu H, Yao Y, Su Z, Yang Y, Kao R, Martin CM and Rui T: Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-/JNK. Am J Physiol Heart Circ Physiol 300: H913-H921, 2011.
38. Okuma Y, Liu K, Wake H, Liu R, Nishimura Y, Hui Z, Teshigawara K, Haruma J, Yamamoto Y, Yamamoto H, et al: Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction. Neuropharmacology 85: 18-26, 2014.
39. Su Z, Yin J, Wang T, Sun Y, Ni P, Ma R, Zhu H, Zheng D, Shen H, Xu W, et al: Up-regulated HMGB1 in EAM directly led to collagen deposition by a PKC/Erk1/2-dependent pathway: Cardiac fibroblast/myofibroblast might be another source of HMGB1. J Cell Mol Med 18: 1740-1751, 2014.
40. Sun X and Tang D: HMGB1-dependent and-independent autophagy. Autophagy 10: 1873-1876, 2014.
41. Germani A, Foglio E, Capogrossi MC, Russo MA and Limana F: Generation of cardiac progenitor cells through epicardial to mesenchymal transition. J Mol Med Berl 93: 735-748, 2015.
42. Bi WR, Xu GT, Lv LX and Yang CQ: The ratio of transforming growth factor-1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis. Genet Mol Res 13: 1005-1014, 2014.
43. Wen SL, Gao JH, Yang WJ, Lu YY, Tong H, Huang ZY, Liu ZX and Tang CW: Celecoxib attenuates hepatic cirrhosis through inhibition of epithelial-to-mesenchymal transition of hepatocytes. J Gastroenterol Hepatol 29: 1932-1942, 2014.
44. Sun S, Ning X, Zhai Y, Du R, Lu Y, He L, Li R, Wu W, Sun W and Wang H: Egr-1 mediates chronic hypoxia-induced renal interstitial fibrosis via the PKC/ERK pathway. Am J Nephrol 39: 436-448, 2014.
45. Hale AN, Ledbetter DJ, Gawriluk TR and Rucker EB III: Autophagy: Regulation and role in development. Autophagy 9: 951-972, 2013.
46. Bánréti A, Sass M and Graba Y: The emerging role of acetylation in the regulation of autophagy. Autophagy 9: 819-829, 2013.
47. Guan JL, Simon AK, Prescott M, Menendez JA, Liu F, Wang F, Wang C, Wolvetang E, Vazquez-Martin A and Zhang J: Autophagy in stem cells. Autophagy 9: 830-849, 2013.
48. Zhang QY, Wu LQ, Zhang T, Han YF and Lin X: Autophagy-mediated HMGB1 release promotes gastric cancer cell survival via RAGE activation of extracellular signal-regulated kinases 1/2. Oncol Rep 33: 1630-1638, 2015.
49. Liu Y and Song L: HMGB1-induced autophagy in Schwann cells promotes neuroblastoma proliferation. Int J Clin Exp Pathol 8: 504-510, 2015.
50. Liu W, Zhang Z, Zhang Y, Chen X, Guo S, Lei Y, Xu Y, Ji C, Bi Z and Wang K: HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway. Cancer Biol Ther 16: 511-517, 2015.
51. Li X, Wang S, Chen Y, Liu G and Yang X: miR-22 targets the 3'UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Tumour Biol 35: 6021-6028, 2014.
52. Yanai H, Matsuda A, An J, Koshiba R, Nishio J, Negishi H, Ikushima H, Onoe T, Ohdan H, Yoshida N, et al: Conditional ablation of HMGB1 in mice reveals its protective function against endotoxemia and bacterial infection. Proc Natl Acad Sci USA 110: 20699-20704, 2013.
53. Yang M, Cao L, Xie M, Yu Y, Kang R, Yang L, Zhao M and Tang D: Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis. Biochem Pharmacol 86: 410-418, 2013.
54. Hagiwara S, Iwasaka H, Koga H, Hasegawa A, Kudo K, Kusaka J, Oyama Y and Noguchi T: Stimulation of autophagy in the liver by lipopolysaccharide-induced systemic inflammation in a rat model of diabetes mellitus. Biomed Res 31: 263-271, 2010.
55. Andersson KB, Florholmen G, Winer LH, Tonnessen T and Christensen G: Regulation of neuronal type genes in congestive heart failure rats. Acta Physiol (Oxf) 186: 17-27, 2006.
56. Agarwal G, Mihai C and Iscru DF: Interaction of discoidin domain receptor 1 with collagen type 1. J Mol Biol 367: 443-455, 2007.
57. Kothiwale S, Borza CM, Lowe EW Jr, Pozzi A and Meiler J: Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery. Drug Discov Today 20: 255-261, 2015.
58. Iwai LK, Luczynski MT and Huang PH: Discoidin domain receptors: A proteomic portrait. Cell Mol Life Sci 71: 3269-3279, 2014.
59. Vogel WF, Abdulhussein R and Ford CE: Sensing extracellular matrix: An update on discoidin domain receptor function. Cell Signal 18: 1108-1116, 2006.